Clinical Trial Update: CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates a consolidation strategy using CD22/CD19 CAR-T cells followed by autologous hematopoietic stem cell transplantation for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD22/CD19 CAR-T (CD22/CD19 chimeric antigen receptor T cells)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING